800 per cent returns: Board likely to announce stock split of equity shares!

800 per cent returns: Board likely to announce stock split of equity shares!

Praveenkumar Yadav
/ Categories: Trending, Mindshare

Shares of this company have gained more than 50 per cent in the last six months.

Cantabil Retail India Limited informed in the exchange filing that the company's board of directors will hold a meeting on October 21, 2023, to discuss and approve the record date for a stock split/sub-division.

In the latest business update of the company, it informed that the company has opened 7 New showrooms & shops at different locations in India during the month of September 2023. Now the total number of showrooms & shops of the company stands at 482.

Also read, How can risk management and diversification open doors to financial success? Find out here 

Cantabil Retail India Limited (CRIL) is involved in designing, manufacturing, branding and retailing of branded apparel and accessories for men, women and kids in the economy to mid-range price segments through a pan-India network of exclusive brand outlets (EBOs) under the flagship brand, Cantabil.

Cantabil Retail India Limited has delivered multibagger returns to its shareholders in the last three years. During this period, shares of Cantabil Retail India Limited surged from Rs 320.90 on October 09, 2020, to Rs 1172.30 on October 06, 2023, an increase of about 260 per cent in a three-year holding period. In the last five years, the shares of the company gained over 800 per cent.

Furthermore, in Q1FY24, the revenue of the company stood at Rs 111.77 crore which increased by 10.92 per cent YoY, while the PAT of the company decreased by 13.11 per cent YoY, staying at Rs 12.27 crore.

The stock has shown tremendous growth and investors should keep a close eye on this stock.

DSIJ’s 'Tiny Treasure' service recommends researched Small-Cap stocks with Inherent Growth Potential. If this interests you, do download the service details here.

Disclaimer: The article is for informational purposes only and not investment advice.

Previous Article Heavy buying: Back-to-back upper circuit in this small-cap multibagger stock; gains over 900 per cent!
Next Article Low PE & High ROE Stock: This bio-pharma company signs commercialization agreement with Juno Pharmaceuticals in Canada!
Rate this article:
4.1

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR